Neomorph
Latest round
- Series B
Last raised
- Apr 2026
Total raised
- $100M
Investors
- 5
About Neomorph
Neomorph, Inc. is engaged in the development of therapeutic solutions by utilizing its proprietary technology platform. Neomorph, Inc. was co-founded in 2020 by Phil Chamberlain, Eric Fischer, Benjamin Ebert and Scott Armstrong. The firm is headquartered in San Diego, US. In April 2026, Neomorph, Inc. Neomorph, Inc. specializes in discovering and developing targeted protein degradation drugs aimed at eliminating disease-causing proteins. Their offerings include molecular glue degraders which repurpose cellular mechanisms to achieve targeted protein degradation, primarily serving pharmaceutical firms in oncology and other therapeutic areas across North America and Europe. The revenue model for Neomorph is centered around collaborations and licensing agreements with global healthcare entities, including upfront fees and milestone payments associated with R&D progress. This transactional structure enables a steady revenue influx while allowing larger partners to spearhead clinical development initiatives.
Who invested in Neomorph
5 investors across 2 rounds
See all investors in Neomorph
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neomorph
Who invested in Neomorph?
Neomorph has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neomorph raised?
Neomorph has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Neomorph last raise money?
Neomorph's most recent round on record is a Series B, in Apr 2026.
What does Neomorph do?
Neomorph is a biotechnology company.
Where is Neomorph headquartered?
Neomorph is headquartered in San Diego, US.
Which VCs invest in companies like Neomorph?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Neomorph's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Neomorph? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.